Walgreens substantially lowered its offering price for drugstore rival
Rite Aid and, facing resistance from U.S. regulators, raised the number
of stores it would be willing to unload to ease monopoly concerns.
The companies initially expected to sell no more than 500 stores, but that was pushed to 1,200 under the new terms announced Monday.